CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE AND CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)	Total	Series A Redeemable Convertible Preferred Stock	Series B Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Losses	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		115,761,842	45,658,957
Beginning balance at Dec. 31, 2021		$ 196,157,000	$ 199,643,000
Ending balance (in shares) at Mar. 31, 2022		115,761,842	45,658,957
Ending balance at Mar. 31, 2022		$ 196,157,000	$ 199,643,000
Beginning balance (in shares) at Dec. 31, 2021				32,413,860
Beginning balance at Dec. 31, 2021	$ (156,241,000)			$ 0	$ 15,162,000	$ (27,000)	$ (171,376,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reclassification of forward contract — related party	12,020,000			$ 1,101,525	12,020,000
Stock-based compensation expense	1,123,000				1,123,000
Change in unrealized loss on investments, net of tax	(5,000)					(5,000)
Net loss	(23,840,000)						(23,840,000)
Ending balance (in shares) at Mar. 31, 2022				33,515,385
Ending balance at Mar. 31, 2022	(166,943,000)			$ 0	28,305,000	(32,000)	(195,216,000)
Beginning balance (in shares) at Dec. 31, 2021		115,761,842	45,658,957
Beginning balance at Dec. 31, 2021		$ 196,157,000	$ 199,643,000
Ending balance (in shares) at Jun. 30, 2022		115,761,842	45,658,957
Ending balance at Jun. 30, 2022		$ 196,157,000	$ 199,643,000
Beginning balance (in shares) at Dec. 31, 2021				32,413,860
Beginning balance at Dec. 31, 2021	(156,241,000)			$ 0	15,162,000	(27,000)	(171,376,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in unrealized loss on investments, net of tax	(123,000)
Net loss	(53,188,000)
Ending balance (in shares) at Jun. 30, 2022				33,512,269
Ending balance at Jun. 30, 2022	(195,063,000)			$ 0	29,651,000	(150,000)	(224,564,000)
Beginning balance (in shares) at Mar. 31, 2022		115,761,842	45,658,957
Beginning balance at Mar. 31, 2022		$ 196,157,000	$ 199,643,000
Ending balance (in shares) at Jun. 30, 2022		115,761,842	45,658,957
Ending balance at Jun. 30, 2022		$ 196,157,000	$ 199,643,000
Beginning balance (in shares) at Mar. 31, 2022				33,515,385
Beginning balance at Mar. 31, 2022	(166,943,000)			$ 0	28,305,000	(32,000)	(195,216,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of unvested restricted common stock (in shares)				(3,116)
Stock-based compensation expense	1,346,000				1,346,000
Change in unrealized loss on investments, net of tax	(118,000)					(118,000)
Net loss	(29,348,000)						(29,348,000)
Ending balance (in shares) at Jun. 30, 2022				33,512,269
Ending balance at Jun. 30, 2022	$ (195,063,000)			$ 0	29,651,000	(150,000)	(224,564,000)
Beginning balance (in shares) at Dec. 31, 2022	97,209,213			97,209,213
Beginning balance at Dec. 31, 2022	$ 316,270,000			$ 2,000	609,849,000	(384,000)	(293,197,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				18,596
Issuance of common stock upon exercise of stock options	68,000				68,000
Stock-based compensation expense	1,681,000				1,681,000
Change in unrealized loss on investments, net of tax	179,000					179,000
Net loss	(39,397,000)						(39,397,000)
Ending balance (in shares) at Mar. 31, 2023				97,227,809
Ending balance at Mar. 31, 2023	$ 278,801,000			$ 2,000	611,598,000	(205,000)	(332,594,000)
Beginning balance (in shares) at Dec. 31, 2022	97,209,213			97,209,213
Beginning balance at Dec. 31, 2022	$ 316,270,000			$ 2,000	609,849,000	(384,000)	(293,197,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	60,702
Change in unrealized loss on investments, net of tax	$ 116,000
Net loss	$ (81,782,000)
Ending balance (in shares) at Jun. 30, 2023	97,269,915			97,269,915
Ending balance at Jun. 30, 2023	$ 240,102,000			$ 2,000	615,347,000	(268,000)	(374,979,000)
Beginning balance (in shares) at Mar. 31, 2023				97,227,809
Beginning balance at Mar. 31, 2023	278,801,000			$ 2,000	611,598,000	(205,000)	(332,594,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				42,106
Issuance of common stock upon exercise of stock options	166,000				166,000
Stock-based compensation expense	3,583,000				3,583,000
Change in unrealized loss on investments, net of tax	(63,000)					(63,000)
Net loss	$ (42,385,000)						(42,385,000)
Ending balance (in shares) at Jun. 30, 2023	97,269,915			97,269,915
Ending balance at Jun. 30, 2023	$ 240,102,000			$ 2,000	$ 615,347,000	$ (268,000)	$ (374,979,000)